Cargando…

Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence

PURPOSE: To predict visual outcomes and treatment needs in a treat & extend (T&E) regimen in neovascular age-related macular degeneration (nAMD) using a machine learning model based on quantitative optical coherence tomography (OCT) imaging biomarkers. MATERIALS AND METHODS: Study eyes of 27...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogunović, Hrvoje, Mares, Virginia, Reiter, Gregor S., Schmidt-Erfurth, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396241/ https://www.ncbi.nlm.nih.gov/pubmed/36017006 http://dx.doi.org/10.3389/fmed.2022.958469

Ejemplares similares

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography
por: Vogl, Wolf-Dieter, et al.
Publicado: (2021)

Point-to-point associations of drusen and hyperreflective foci volumes with retinal sensitivity in non-exudative age-related macular degeneration
por: Reiter, Gregor S., et al.
Publicado: (2023)

Correlation of vascular and fluid‐related parameters in neovascular age‐related macular degeneration using deep learning
por: Schranz, Markus, et al.
Publicado: (2022)

Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)—a phase III, prospective, multicentre, randomized study: design and methods
por: Coulibaly, Leonard M., et al.
Publicado: (2022)

Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
por: Schütze, Christopher, et al.
Publicado: (2015)

Topographic Distribution and Progression of Soft Drusen Volume in Age-Related Macular Degeneration Implicate Neurobiology of Fovea
por: Pollreisz, Andreas, et al.
Publicado: (2021)

Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
por: Schmidt-Erfurth, Ursula, et al.
Publicado: (2022)

Profiling neovascular age‐related macular degeneration choroidal neovascularization lesion response to anti‐vascular endothelial growth factor therapy using SSOCTA
por: Told, Reinhard, et al.
Publicado: (2020)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?
por: Haj Najeeb, Bilal, et al.
Publicado: (2022)

Short‐time effect of intravitreal injections on retinal vascular oxygenation and vessel diameter in patients with diabetic macular oedema or neovascular age‐related macular degeneration
por: Mitsch, Christoph, et al.
Publicado: (2019)

Automated Quantification of Photoreceptor alteration in macular disease using Optical Coherence Tomography and Deep Learning
por: Orlando, José Ignacio, et al.
Publicado: (2020)

Few-shot out-of-distribution detection for automated screening in retinal OCT images using deep learning
por: Araújo, Teresa, et al.
Publicado: (2023)

Artificial intelligence-based predictions in neovascular age-related macular degeneration
por: Ferrara, Daniela, et al.
Publicado: (2021)

Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration
por: Roberts, Philipp K., et al.
Publicado: (2022)

Retinal oxygen saturation, vessel diameter and flicker response in eyes with specific subtypes of neovascular age-related macular degeneration during aflibercept treatment
por: Sacu, Stefan, et al.
Publicado: (2022)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
por: von der Emde, Leon, et al.
Publicado: (2019)

Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment
por: Mai, Julia, et al.
Publicado: (2023)

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
por: Schmidt-Erfurth, Ursula, et al.
Publicado: (2014)

Comparison of Optical Coherence Angiography Measurements in Patients with Neovascular and Non-Neovascular Age-Related Macular Degeneration
por: Demir, Mehmet, et al.
Publicado: (2022)

Prognostic Optical Coherence Tomography Biomarkers in Neovascular Age-Related Macular Degeneration
por: Nawash, Baraa, et al.
Publicado: (2023)

Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration
por: Cabral, Diogo, et al.
Publicado: (2020)

The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
por: Hanumunthadu, Daren, et al.
Publicado: (2017)

Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration
por: Rosenfeld, Philip J.
Publicado: (2016)

Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography
por: Schlanitz, Ferdinand G., et al.
Publicado: (2015)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration
por: Teo, Kelvin Y. C., et al.
Publicado: (2022)

Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography
por: Bae, Kunho, et al.
Publicado: (2019)

Recurrence of neovascular age-related macular degeneration after cessation of treat and extend regimen
por: Hirata, Yuki, et al.
Publicado: (2022)

Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning
por: Waldstein, Sebastian M., et al.
Publicado: (2017)

One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2022)

Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2023)

Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission
por: Coscas, Florence, et al.
Publicado: (2018)

OPTICAL COHERENCE TOMOGRAPHY, FLUORESCEIN ANGIOGRAPHY, AND DIAGNOSIS OF CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
por: Gualino, Vincent, et al.
Publicado: (2019)

Features and Diagnostic Accuracy of Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration
por: Usman, Maria, et al.
Publicado: (2019)

Need for manual segmentation in optical coherence tomography angiography of neovascular age-related macular degeneration
por: Dabir, Supriya, et al.
Publicado: (2020)

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Kaiser, Peter K., et al.
Publicado: (2021)

Sub-retinal pigment epithelium tubules in non-neovascular age-related macular degeneration
por: Fragiotta, Serena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vmt8qr6ob03o92o6bope2pgan3